Drug Information

General Information
Drug ID
DR01349
Drug Name
Karenitecin
Synonyms
Karenitecin (TN)
Drug Type
Small molecular drug
Indication Ovarian cancer [ICD11: 2C73] Phase 3 [1]
Structure
3D MOL 2D MOL
Formula
C25H28N2O4Si
Canonical SMILES
CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O
InChI
InChI=1S/C25H28N2O4Si/c1-5-25(30)19-12-21-22-17(13-27(21)23(28)18(19)14-31-24(25)29)15(10-11-32(2,3)4)16-8-6-7-9-20(16)26-22/h6-9,12,30H,5,10-11,13-14H2,1-4H3/t25-/m0/s1
InChIKey
POADTFBBIXOWFJ-VWLOTQADSA-N
CAS Number
CAS 203923-89-1
Pharmaceutical Properties Molecular Weight 448.6 Topological Polar Surface Area 79.7
Heavy Atom Count 32 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 5
PubChem CID
148202
PubChem SID
530668 , 10249845 , 11443149 , 14906395 , 46225149 , 50873155 , 57346730 , 96026007 , 104418481 , 126681210 , 135105770 , 140587255 , 172918703 , 175427037 , 184826536 , 198949673 , 223663599 , 228436255 , 241051100 , 242534801 , 246301288 , 252215634
TTD Drug ID
D02CZK
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [3]
References
1 ClinicalTrials.gov (NCT00477282) Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
2 Pharmacogenomic importance of ABCG2. Pharmacogenomics. 2008 Aug;9(8):1005-9.
3 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.